Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
Authors:
- John J. CoenJCJohn J. Coen
- Jonathan J. PalyJPJonathan J. Paly
- Andrzej NiemierkoANAndrzej Niemierko
- Donald S. KaufmanDKDonald S. Kaufman
- Niall M. HeneyNHNiall M. Heney
- Daphne Y. SpiegelDSDaphne Y. Spiegel
- Jason A. EfstathiouJEJason A. Efstathiou
- Anthony L. ZietmanAZAnthony L. Zietman
- William U. ShipleyWSWilliam U. Shipley
- 1 June 2013
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 86 (2) , 311-316
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH ExperienceEuropean Urology, 2012
- Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative StudyJournal of Urology, 2011
- Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In SituJournal of Clinical Oncology, 2010
- Evidence for the usefulness of nomogramsNature Reviews Endocrinology, 2007
- Trimodality Treatment and Selective Organ Preservation for Bladder CancerJournal of Clinical Oncology, 2006
- Are Nomograms Better Than Currently Available Stage Groupings for Bladder Cancer?Journal of Clinical Oncology, 2006
- Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast CancerJournal of Clinical Oncology, 2005
- Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2005
- Overview of bladder cancer trials in the Radiation Therapy Oncology GroupCancer, 2003
- Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancerCurrent Opinion in Urology, 2003